Abdominal aortic aneurysm enlargement of the large blood vessel
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Male or female > 18 years of age - BMI * 30 kg/m2 - Infrarenal AAA - Scheduled for elective EVAR - Informed consent form understood and signed, and agrees to all visits
Exclusion criteria
Exclusion criteria: - Hypersensitivity to the active substance(s) or any of the excipients in Sonovue - Right-to-left cardiac shunt - Severe pulmonary hypertension (pulmonary artery pressure > 90mmHg) - Uncontrolled systemic hypertension - Severe pulmonary disease (e.g. COPD GOLD 3 or 4, adult respiratory distress syndrome) - Clinically unstable cardiac disease (recent,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vector velocity data derived from the echoPIV analysis will be used to calculate and visualize the spatiotemporal blood flow velocity profiles. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Vector velocity data derived from the PC MRI scan will be used to calculate and visualize the spatiotemporal blood flow velocity profiles and to validate the echoPIV results. - Pre- and postoperative spatiotemporal velocity profiles obtained with echoPIV will be compared to evaluate the influence of the placement of a stent graft on local hemodynamics. - From both datasets blood flow derived parameters, such as vector complexity and vorticity, will be calculated. Moreover, specific blood flow patterns like recirculations or blood stasis will be evaluated thoroughly. | — |
Countries
Netherlands